Bioequivalence testing of combined generic preparations to be made compulsory
Published: 2008-09-11 06:59:00
Updated: 2008-09-11 06:59:00
The Korea Food and Drug Administration has unveiled its plan to introduce the mandatory bioequivalence testing of combined generic preparations to screen the clinical effectiveness of these medicines, when compared to original brand items.
The KFDA said in its report to the National Assembly t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
